Strata Critical Medical (SRTA) Insider & Congress Trades

Smart money at a glance

Filings to Nov 9, 2026

Net buying: insiders sold $0 and bought $10K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$10K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about SRTA filings

Are insiders buying or selling Strata Critical Medical, Inc. (SRTA) stock?

Net buying: insiders sold $0 and bought $10K of SRTA stock on the open market in the 90 days to Nov 9, 2026, according to SEC Form 4 filings. The largest was Lauck, Andrew (Director), who bought $10K. The latest filing was on Nov 9, 2026.

Which members of Congress have traded SRTA recently?

None. No member of Congress disclosed a SRTA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SRTA smart-money data?

This summary uses filings available on Nov 9, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on SRTA

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean short1 buy · 2 sales
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about SRTA filings

Are insiders buying or selling Strata Critical Medical, Inc. (SRTA) stock?

Which members of Congress have traded SRTA recently?

None. No member of Congress disclosed a SRTA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SRTA smart-money data?

Insiders

What insiders are doing

7 trades · 6 mo

Bought$10KSold$749K

Buys (1)

LA
Lauck Andrew
Dir · Nov 9
$10K
bought

Sells (2)

LR
Love Reginald
Dir · Aug 13
$29K
sold
HW
Heyburn William A.
Co-CEO and CFO · Cluster · Jun 10
$186K
sold
Signals like this: n=8070, 50% finished lower at D15, median -0.1% vs SPY +0.7%

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Other smart money signals

Activist stakes, short interest & more

1 item

SI
Short Interest ChangeModerate
short-volume tape softening: latest 29.6% fell 20.6pp vs 19d avg 50.1%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 3, 2026

Earnings came in $0.06 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 3, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.05-$0.06 miss

$0.01 expected

Revenue

$74.1M

SEC filing

Next report

Estimated report: Nov 9, 2026, today

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 3, 2026	-$0.05est. $0.01	-$0.06miss	$74.1MSEC filing	+50.3%from $49.3M
Jun 30, 2026Reported Aug 4, 2026	-$0.01est. -$0.01	+$0.00in line	$72.5MSEC filing	+60.7%from $45.1M
Mar 31, 2026Reported May 6, 2026	$0.04est. -$0.04	+$0.08beat	$67.4MSEC filing	+87.4%from $35.9M
Dec 31, 2025Reported Mar 3, 2026	-$0.12est. $0.06	-$0.18miss	$66.8MAlpha Vantage	+22.9%from $54.4M
Sep 30, 2025Reported Nov 10, 2025	-$0.12est. -$0.02	-$0.10miss	$49.3MSEC filing	+36.7%from $36.1M
Jun 30, 2025Reported Aug 5, 2025	-$0.04est. -$0.05	+$0.01beat	$45.1MSEC filing	-33.6%from $67.9M
Mar 31, 2025Reported May 12, 2025	-$0.07est. -$0.10	+30.00%beat	$35.9MSEC filing	-30.2%from $51.5M
Dec 31, 2024Reported Mar 13, 2025	-$0.13est. -$0.12	-10.60%miss	$54.4MAlpha Vantage	+14.5%from $47.5M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $5.23
High: $5.62
Low: $5.16
Prev close: $5.26
52-wk high: $6.50
52-wk low: $3.95
Mkt cap: $496.6M
ROE: -7.5%
Fwd P/E: 138.9x
Beta: 2.56
P/S: 1.8x
P/B: 1.8x
Profit margin: -8.8%
Op margin: -6.6%

Dec 2025 to Sep 2026

What it sold, what it cost, what was left.

RevenueProfit

Dec 2025Mar 2026Jun 2026Sep 2026

Income statement, 4 periods, all values in US dollars
USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
What came in
RevenueTotal revenue	$66.8M	$67.4M	$72.5M	$74.1M
Cost of what it soldCost of revenue	$55.1M	$53.3M	$57.3M	$57.3M
Gross profit	$11.7M	$14.1M	$15.2M	$16.8M
What it spent
Research and development	$1.7M	$1.1M	$1.0M	—
Sales and adminSelling, general and administrative	$16.8M	$15.6M	$8.8M	$15.1M
Other operating costsOperating costs not itemised in the filing's summary	-$448.0K	$368.0K	$10.8M	$5.6M
Total operating expenses	$18.1M	$17.1M	$20.6M	$20.7M
What was left
Operating profitOperating income	-$6.4M	-$3.0M	-$5.4M	-$3.8M
Profit before tax	-$5.4M	$2.4M	-$10.5M	-$7.6M
TaxIncome tax expense	$3.4M	$248.0K	—	—
Net profitNet income	-$8.8M	$2.2M	-$10.5M	-$7.6M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$558.0K	$1.2M	-$2.0M	-$7.6M

Technicals

Price structure

This stock is in a strong uptrend, and looks overbought after a fast run-up.

Trend

Strong uptrend

85 / 100

RSI 14

73overbought

20D volatility

73%annualized

52-week range

$5.56

$3.95$6.50

20D support

$4.21recent floor

20D resistance

$5.62recent ceiling

Returns

5D +25.2%20D +22.7%60D -6.9%

Price vs moving averages

SMA20 +18.7%SMA50 +11.5%SMA200 +9.5%

Volume pace

1.38xvs prior 20D

12 macro signals shaping SRTA right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 3, 2026

-$0.05est. $0.01

-$0.06

$74.1MSEC filing

+50.3%from $49.3M

Jun 30, 2026Aug 4, 2026

-$0.01est. -$0.01

+$0.00

$72.5MSEC filing

+60.7%from $45.1M

Mar 31, 2026May 6, 2026

$0.04est. -$0.04

+$0.08

$67.4MSEC filing

+87.4%from $35.9M

Dec 31, 2025Mar 3, 2026

-$0.12est. $0.06

-$0.18

$66.8MAlpha Vantage

+22.9%from $54.4M

Sep 30, 2025Nov 10, 2025

-$0.12est. -$0.02

-$0.10

$49.3MSEC filing

+36.7%from $36.1M

Jun 30, 2025Aug 5, 2025

-$0.04est. -$0.05

+$0.01

$45.1MSEC filing

-33.6%from $67.9M

Mar 31, 2025May 12, 2025

-$0.07est. -$0.10

+30.00%

$35.9MSEC filing

-30.2%from $51.5M

Dec 31, 2024Mar 13, 2025

-$0.13est. -$0.12

-10.60%

$54.4MAlpha Vantage

+14.5%from $47.5M

Income statement, 4 periods, all values in US dollars
USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
What came in
RevenueTotal revenue	$66.8M	$67.4M	$72.5M	$74.1M
Cost of what it soldCost of revenue	$55.1M	$53.3M	$57.3M	$57.3M
Gross profit	$11.7M	$14.1M	$15.2M	$16.8M
What it spent
Research and development	$1.7M	$1.1M	$1.0M	—
Sales and adminSelling, general and administrative	$16.8M	$15.6M	$8.8M	$15.1M
Other operating costsOperating costs not itemised in the filing's summary	-$448.0K	$368.0K	$10.8M	$5.6M
Total operating expenses	$18.1M	$17.1M	$20.6M	$20.7M
What was left
Operating profitOperating income	-$6.4M	-$3.0M	-$5.4M	-$3.8M
Profit before tax	-$5.4M	$2.4M	-$10.5M	-$7.6M
TaxIncome tax expense	$3.4M	$248.0K	—	—
Net profitNet income	-$8.8M	$2.2M	-$10.5M	-$7.6M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$558.0K	$1.2M	-$2.0M	-$7.6M

USD

Dec 2025

Mar 2026

Jun 2026

Sep 2026

What came in

RevenueTotal revenue

$66.8M

$67.4M

$72.5M

$74.1M

Cost of what it soldCost of revenue

$55.1M

$53.3M

$57.3M

Gross profit

$11.7M

$14.1M

$15.2M

$16.8M

What it spent

Research and development

$1.7M

$1.1M

$1.0M

—

Sales and adminSelling, general and administrative

$16.8M

$15.6M

$8.8M

$15.1M

Other operating costsOperating costs not itemised in the filing's summary

-$448.0K

$368.0K

$10.8M

$5.6M

Total operating expenses

$18.1M

$17.1M

$20.6M

$20.7M

What was left

Operating profitOperating income

-$6.4M

-$3.0M

-$5.4M

-$3.8M

Profit before tax

-$5.4M

$2.4M

-$10.5M

-$7.6M

TaxIncome tax expense

$3.4M

$248.0K

—

Net profitNet income

-$8.8M

$2.2M

-$10.5M

-$7.6M

EBITDAEarnings before interest, tax, depreciation, amortisation

-$558.0K

$1.2M

-$2.0M

-$7.6M

Strata Critical Medical, Inc.

Smart money at a glance

What do analysts expect?

Questions about SRTA filings

Smart money on SRTA

Questions about SRTA filings

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in $0.06 a share below what analysts expected.

Estimated report: Nov 9, 2026, today

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Strata Critical Medical, Inc.

Smart money at a glance

What do analysts expect?

Questions about SRTA filings

Smart money on SRTA

Questions about SRTA filings

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in $0.06 a share below what analysts expected.

Estimated report: Nov 9, 2026, today

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Strata Critical Medical, Inc.

Overview

Questions about SRTA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.

Strata Critical Medical, Inc.

Overview

Questions about SRTA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.